CR11220A - Derivados de pirimidina 934 - Google Patents

Derivados de pirimidina 934

Info

Publication number
CR11220A
CR11220A CR11220A CR11220A CR11220A CR 11220 A CR11220 A CR 11220A CR 11220 A CR11220 A CR 11220A CR 11220 A CR11220 A CR 11220A CR 11220 A CR11220 A CR 11220A
Authority
CR
Costa Rica
Prior art keywords
pirimidine derivatives
pirimidine
derivatives
ring
condensed
Prior art date
Application number
CR11220A
Other languages
English (en)
Inventor
Berbard Christophe Barlaam
Richard Ducray
Jason Grant Kettle
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CR11220A publication Critical patent/CR11220A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto de formula (i) en la que de A1, A2 o A3 es A3 es N y los otros se relacionan independientemente de CH o N; en anillo B es un anillo carbociclico o heterocicco de 5 o 6 miembros condensado que esta opcialmente sustituido como se define en la memoria descriptiva, y R1; R2, R3, R4 y n son como se define en la memoria decriptiva.
CR11220A 2007-07-16 2010-01-15 Derivados de pirimidina 934 CR11220A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07301236 2007-07-16

Publications (1)

Publication Number Publication Date
CR11220A true CR11220A (es) 2010-05-20

Family

ID=40260140

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11220A CR11220A (es) 2007-07-16 2010-01-15 Derivados de pirimidina 934

Country Status (18)

Country Link
US (1) US7718653B2 (es)
EP (1) EP2183242A2 (es)
JP (1) JP2010533700A (es)
KR (1) KR20100042272A (es)
CN (1) CN101796046A (es)
AU (1) AU2008277446A1 (es)
BR (1) BRPI0814821A2 (es)
CA (1) CA2693880A1 (es)
CO (1) CO6260075A2 (es)
CR (1) CR11220A (es)
DO (1) DOP2010000022A (es)
EA (1) EA201000101A1 (es)
EC (1) ECSP109958A (es)
MX (1) MX2010000658A (es)
NI (1) NI201000011A (es)
SV (1) SV2010003459A (es)
WO (1) WO2009010789A2 (es)
ZA (1) ZA201000107B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103003264B (zh) 2010-05-21 2014-08-06 切米利亚股份公司 嘧啶衍生物
CA2830129C (en) 2011-03-24 2016-07-19 Chemilia Ab Novel pyrimidine derivatives
AU2012245387C1 (en) 2011-04-22 2016-05-05 Signal Pharmaceuticals, Llc Substituted Diaminocarboxamide and Diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US9953761B2 (en) 2011-05-03 2018-04-24 Phoenix Contact Gmbh & Co. Kg Arrangement and method for contactless energy transmission with a coupling-minimized matrix of planar transmission coils
CN103222842B (zh) 2013-04-18 2015-09-09 安翰光电技术（武汉）有限公司 一种控制胶囊内窥镜在人体消化道运动的装置及方法
NZ715903A (en) 2014-01-30 2017-06-30 Signal Pharm Llc Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
WO2016100308A1 (en) 2014-12-16 2016-06-23 Signal Pharmaceuticals, Llc Methods for measurement of inhibition of c-jun n-terminal kinase in skin
ES2877642T3 (es) 2014-12-16 2021-11-17 Signal Pharm Llc Formulaciones de 2-(terc-butilamino)-4-((1R,3R,4R)-3-hidroxi-4-metilciclohexilamino)-pirimidin-5-carboxamida
US20180022710A1 (en) 2015-01-29 2018-01-25 Signal Pharmaceuticals, Llc Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
EP3795553B1 (en) 2015-07-24 2024-05-15 Celgene Corporation Methods of synthesis of (1r,2r,5r)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein
CN106543089A (zh) * 2016-11-04 2017-03-29 山东铂源药业有限公司 一种达沙替尼中间体的合成方法
CA3180623A1 (en) * 2020-05-29 2021-12-02 Changyou MA Pyrimidine compound as axl inhibitor
CN116178433A (zh) * 2021-11-26 2023-05-30 南京正大天晴制药有限公司 Axl激酶抑制剂的盐及其制备方法和用途
CN116178434A (zh) * 2021-11-26 2023-05-30 南京正大天晴制药有限公司 Axl激酶抑制剂的单对甲苯磺酸盐及其晶型

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02007957A (es) * 2000-02-17 2002-11-29 Amgen Inc Inhibidores de cinasas.
CA2474246C (en) 2002-03-05 2010-06-29 Astrazeneca Ab Alkylammonium salts of omeprazole and esomeprazole
GB0305929D0 (en) * 2003-03-14 2003-04-23 Novartis Ag Organic compounds
BR122019017579B8 (pt) * 2003-08-15 2021-07-27 Novartis Ag 2,4-pirimidinadiaminas, seus usos, combinação e composição farmacêutica
US7521457B2 (en) * 2004-08-20 2009-04-21 Boehringer Ingelheim International Gmbh Pyrimidines as PLK inhibitors
GB0419161D0 (en) * 2004-08-27 2004-09-29 Novartis Ag Organic compounds
JP2008533166A (ja) 2005-03-16 2008-08-21 ターゲジェン インコーポレーティッド ピリミジン化合物および使用法
WO2006129100A1 (en) * 2005-06-03 2006-12-07 Glaxo Group Limited Novel compounds
AR054834A1 (es) 2005-07-15 2007-07-18 Glaxo Group Ltd Derivados de 1,1-dioxido-2,3-dihidro-1,2-benzoisotiazol-6-il-1h-indazol-4-il-2,4 pirimidina diamina
WO2007028445A1 (en) * 2005-07-15 2007-03-15 Glaxo Group Limited 6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives
WO2007035309A1 (en) 2005-09-15 2007-03-29 Merck & Co., Inc. Tyrosine kinase inhibitors
NZ567851A (en) * 2005-11-01 2011-09-30 Targegen Inc Bi-aryl meta-pyrimidine inhibitors of kinases
TW200736232A (en) 2006-01-26 2007-10-01 Astrazeneca Ab Pyrimidine derivatives
WO2007085540A1 (en) 2006-01-27 2007-08-02 Glaxo Group Limited 1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives
TW200840581A (en) * 2007-02-28 2008-10-16 Astrazeneca Ab Novel pyrimidine derivatives
US7947698B2 (en) * 2007-03-23 2011-05-24 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the JAK pathway
KR20100017441A (ko) 2007-04-27 2010-02-16 아스트라제네카 아베 증식성 병태를 치료하기 위한 ＥｐｈＢ4 키나제 억제제로서의 Ｎ'-(페닐)-Ｎ-(모르폴린-4-일-피리딘-2-일)-피리미딘-2,4-디아민 유도체

Also Published As

Publication number Publication date
ECSP109958A (es) 2010-03-31
JP2010533700A (ja) 2010-10-28
ZA201000107B (en) 2010-09-29
SV2010003459A (es) 2010-04-30
WO2009010789A3 (en) 2009-05-07
DOP2010000022A (es) 2010-02-15
CN101796046A (zh) 2010-08-04
CA2693880A1 (en) 2009-01-22
MX2010000658A (es) 2010-03-26
EA201000101A1 (ru) 2010-08-30
EP2183242A2 (en) 2010-05-12
BRPI0814821A2 (pt) 2015-02-03
NI201000011A (es) 2010-12-07
WO2009010789A2 (en) 2009-01-22
US7718653B2 (en) 2010-05-18
US20090023719A1 (en) 2009-01-22
CO6260075A2 (es) 2011-03-22
AU2008277446A1 (en) 2009-01-22
KR20100042272A (ko) 2010-04-23

Similar Documents

Publication Publication Date Title
CR11220A (es) Derivados de pirimidina 934
SV2010003598A (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
ECSP109922A (es) Compuestos de pirazol y su uso como inhibidores raf
CL2009000323A1 (es) Compuestos derivados de heterociclos no condensados sustituidos, inhibidores de la funcion de la proteina ns5a; composicion farmaceutica que los comprende; y su uso para tratar la infeccion del virus de la hepatitis c.
AR058124A1 (es) Derivados de ftalazinona como inhibidores de parp-1
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
MX2014002770A (es) Nuevos derivados dihidroquinolina-2-ona.
PA8843701A1 (es) Derivados de indolina y métodos para usarlos
CO5640117A2 (es) Derivados de 2,4-diamonopirimidina
CO6321239A2 (es) Derivados de isoxazol y su uso como potenciadores de los receptores metabotropicos de glutamato
UY31750A (es) Compuestos y composiciones como inhibidores de quinasa
CR10243A (es) "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos"
GT200500238A (es) Fenilaminotiazoles sustituidos y su uso
CO2022003062A2 (es) Compuestos heterocíclicos
ECSP099565A (es) Compuesto de 2-amino pirimidina
HN2011000076A (es) Derivados de piridino-piridinonas, su preparacion.
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
CR20110062A (es) Nuevos derivados de acilaminobenzamida
CL2023002429A1 (es) Derivados novedosos de pirimidin-2-il sulfonamida
ECSP099791A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparación y su aplicación en terapéutica
UY31905A (es) Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
CO6331335A2 (es) Nuevos compuestos antagonistas de los receptores b1 de bradiquinina
ECSP099679A (es) Nuevos compuestos y sus usos 707
AR055666A1 (es) Inhibidores inntr
UY29879A1 (es) Derivados de 6-heteroarilpiridoindolona, su preparación y su aplicación en terapéutica

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)